Developer docs
API playgroundTry for free, no card

Search company profiles

Priority STD Testing

Full company profile

uuid003jufv

Namestring
Priority STD Testing
Legal namestring
Priority STD Testing
Company typeenum
Private
Founded yearint
2001
Descriptiontext

Priority STD Testing is a privately held direct-to-consumer STD testing service founded in 2001 and headquartered in St. Louis, Missouri, operating with a team of 1-10 employees. The company enables individuals to purchase FDA-approved laboratory tests online or via phone 24/7, then visit one of more than 4,000 affiliated Quest Diagnostics collection facilities nationwide for sample collection, with results delivered through a secure HIPAA-compliant patient portal typically within 24-48 hours. The company's stated cumulative volume is over 100,000 individuals tested since inception.

The product portfolio spans individual tests priced from $69 to $159 and bundled panels, anchored by a $129 Twin STD Panel (Chlamydia and Gonorrhea) and a $249 10-Panel Test covering HIV (1 Ab, 1 Ag, 2 Ab), Hepatitis B and C, Syphilis, and Herpes 1/2. Specialty offerings include an HIV RNA Early Detection test capable of identifying the virus within 10 days of exposure, Herpes Early Detection with automatic confirmatory Inhibition testing for HSV-2 positives, and a Mycoplasma Genitalium test. Treatment services are provided through PWNHealth-affiliated physicians who conduct phone or video consultations and can prescribe medication for positive Chlamydia, Gonorrhea, or Trichomoniasis results, with a $65 consultation fee.

The business operates on a unit-pricing, pay-as-you-go model with no subscription component. Revenue is generated entirely from upfront test purchases plus optional physician consultation fees; there are no disclosed enterprise contracts, insurance billing arrangements, or recurring revenue streams. Marketing is primarily organic: SEO-optimized educational blog content, organic search, phone-based care counselors, Trustpilot review collection, and earned media coverage in Healthline, Vice, Huffington Post, and Men's Health. All laboratory processing is conducted in CLIA-certified labs via the Quest Diagnostics partnership, and the company is verified as a CDC NPIN provider.

Short descriptiontext

Priority STD Testing is a St. Louis-based direct-to-consumer STD testing service that sells FDA-approved lab tests online and by phone, processing samples through Quest Diagnostics' 4,000+ collection facilities and delivering results via a secure patient portal within 24-48 hours.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSt Louis, United States
HQ citystring
St Louis
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
STD testing services, direct-to-consumer testing, sexual health screening, lab testing panels, telehealth consultations
Industry4 codes
PRIMARYHLALAIAL
Infectious Disease & STI Testing-to-Treatment with eRx + Pharmacy Fulfillment
Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms
SECONDARYHLAHAOAA
Infectious Disease POCT (Respiratory, STI, HIV, Sepsis)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Point-of-Care Testing (POCT) & Rapid Diagnostics
SECONDARYHLACAPAK
Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLAGAEAK
Point-of-Care & Decentralized Trial Testing Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)
NAICS code2 codes
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories62151
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Direct-to-Consumer STD Testing Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Direct Test Sales
TypeOne Time License
Description

One-time purchase of STD testing panels and individual tests. Customers order online or by phone, pay upfront, then visit Quest Diagnostics collection facilities for sample collection. Additional $65 physician consultation fee for treatment consultations.

prioritystdtesting.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Operations, Marketing or Sales, Personnel, Technology or R&D, Infrastructure
Pricing details5 tiers
1Twin STD Panel - Chlamydia and Gonorrhea
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$129 - Includes testing for Chlamydia and Gonorrhea

prioritystdtesting.com
210-Panel STD Test - Comprehensive
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$249 - Most popular option. Includes Hepatitis B, Hepatitis C, Syphilis, Herpes 1, Herpes 2, HIV 1 Ab, HIV 1 Ag, HIV 2 Ab, plus Chlamydia and Gonorrhea (based on typical 10-panel composition)

prioritystdtesting.com
3Individual STD Tests
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Chlamydia - $99, Gonorrhea - $99, Hepatitis B - $69, Hepatitis C - $69, Herpes I/II - $109, HIV 1/2 - $89, Syphilis - $79, Trichomoniasis - $139, Mycoplasma Genitalium - $159

prioritystdtesting.com
4New York State Individual Tests
ModelUnit PricingBilling cadencePay-as-you-go
Notes

NY-specific pricing: HIV 4th Gen - $23.00, HIV RNA - $90.00, HSV 1/2 IgG - $11.00, Chlamydia - $11.50, Gonorrhea - $11.50, Trichomoniasis - $25.00, Syphilis - $5.77, Hepatitis B - $4.80, Hepatitis C - $8.25. These are lab fees; physician ordering fees are separate.

prioritystdtesting.com
5Physician Treatment Consultation
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$65 treatment consult fee for phone/video consultation with PWNHealth physician following positive test results for chlamydia, gonorrhea, or trichomoniasis. New York residents receive post-test physician consult included in service fee.

prioritystdtesting.com
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

Priority STD Testing is a direct-to-consumer STD testing service that lets individuals privately order lab tests online or by phone, visit any of 4,000+ Quest Diagnostics collection facilities nationwide without an appointment for sample collection, and receive confidential results through a secure online portal in 24-48 hours. The company also offers integrated physician consultations and treatment via PWNHealth for positive chlamydia, gonorrhea, or trichomoniasis results, with prescriptions called into local pharmacies.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Results available in 24-48 hours
+2 more records
Product overview1 text field

Priority STD Testing operates as a direct-to-consumer STD testing service offering a portfolio of individual tests and bundled panels. The core product lineup includes the Twin STD Panel (Chlamydia and Gonorrhea) and the 10-Panel STD Test as the most comprehensive option covering Hepatitis B, Hepatitis C, Syphilis, Herpes 1/2, and HIV 1/2. Individual standalone tests are available for each condition: Chlamydia ($99), Gonorrhea ($99), Hepatitis B ($69), Hepatitis C ($69), Herpes I/II ($109), HIV 1/2 ($89), Syphilis ($79), Trichomoniasis ($139), and Mycoplasma Genitalium ($159). Advanced early detection tests are offered for HIV RNA (detecting virus as early as 10 days post-exposure) and Herpes. The company also provides complementary physician consultation and treatment services through its PWNHealth partnership, enabling phone/video consults and prescriptions for positive results of curable STDs (Chlamydia, Gonorrhea, Trichomoniasis). Testing is conducted at over 4,000 private collection facilities nationwide with results typically available within 24-72 hours.

Product and service15 records
1Twin STD Panel (Chlamydia and Gonorrhea)
CategorySTD Testing Panel
Description

Dual-test panel that screens for Chlamydia and Gonorrhea infections, priced at $129, for consumers wanting focused bacterial STD screening.

210-Panel STD Test
CategorySTD Testing Panel
Description

Comprehensive 10-panel test covering Hepatitis B, Hepatitis C, Syphilis, Herpes 1, Herpes 2, HIV 1 Ab, HIV 1 Ag, HIV 2 Ab (plus Chlamydia and Gonorrhea per typical 10-panel composition), priced at $249 as the most popular option.

3Individual Chlamydia Test
CategoryIndividual STD Test
Description

Standalone urine/blood test for Chlamydia infection, priced at $99, for patients seeking single-disease screening.

4Individual Gonorrhea Test
CategoryIndividual STD Test
Description

Standalone test for Gonorrhea infection, priced at $99, allowing targeted screening for this bacterial STD.

5Individual Hepatitis B Test
CategoryIndividual STD Test
Description

Standalone blood test for Hepatitis B virus, priced at $69, screening for liver infection transmittable through sexual contact and blood.

6Individual Hepatitis C Test
CategoryIndividual STD Test
Description

Standalone test for Hepatitis C virus, priced at $69, detecting blood-borne liver infection that can be transmitted sexually.

7Herpes I/II Test
CategoryIndividual STD Test
Description

Blood test detecting both Herpes Simplex Virus Type 1 (oral herpes) and Type 2 (genital herpes) antibodies, priced at $109.

8HIV 1/2 Test
CategoryIndividual STD Test
Description

Standard 4th generation HIV test detecting both HIV-1 and HIV-2 antibodies, priced at $89.

9Individual Syphilis Test
CategoryIndividual STD Test
Description

Blood test for Syphilis infection, priced at $79, screening for antibodies to Treponema pallidum bacterium.

10Individual Trichomoniasis Test
CategoryIndividual STD Test
Description

Urine test for Trichomoniasis infection, priced at $139, screening for the Trichomonas vaginalis parasite.

11Mycoplasma Genitalium Test
CategoryIndividual STD Test
Description

Test for Mycoplasma genitalium infection, priced at $159, offered as part of the company's expanded STD testing menu.

12HIV RNA Early Detection Test
CategoryIndividual STD Test
Description

Advanced HIV test detecting viral RNA rather than antibodies, enabling detection as early as 10 days after exposure; results typically process in about 5 business days due to specialty lab requirements.

13Herpes Early Detection Test
CategoryIndividual STD Test
Description

Early detection testing for Herpes simplex virus, with automatic confirmatory inhibition testing for HSV-2 positive results at no additional charge.

14Physician Consultation Service
CategoryTelehealth Consultation
Description

Phone or video consultation with a PWNHealth physician for patients testing positive for Chlamydia, Gonorrhea, or Trichomoniasis, at a $65 consultation fee, enabling prescription medication without an office visit.

15Treatment Services
CategoryTreatment Services
Description

Prescription treatment for patients testing positive for Chlamydia, Gonorrhea, or Trichomoniasis, with medication called into the patient's pharmacy of choice and typically available same day, delivered via PWNHealth physicians.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Quest Diagnostics is the primary laboratory partner responsible for collecting and processing all samples. They operate the 4,000+ collection facilities where customers provide urine and blood samples. Quest Diagnostics is in compliance with federal, state, and local health reporting requirements.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

PWNHealth provides administrative services including physician review of test orders, results delivery through secure patient portal, and phone/video consultations for treatment of positive results. PWN physicians can prescribe medication for chlamydia, gonorrhea, and trichomoniasis. Located at 123 W 18th St, New York, NY 10011.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Trustpilot is used to collect and display customer reviews of the testing experience. Automated review requests are sent via email after testing is complete. No medically related information is disclosed in the review system.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight3 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

At-home STI testing company offering mail-in sample collection kits covering chlamydia, gonorrhea, HIV, HPV, and other infections. Competes for the same privacy-conscious, insurance-avoiding consumer segment but differentiates through home collection rather than walk-in labs.

2Roman (Ro)
TypeEmerging player
Description

Telehealth company offering men's sexual health services including STI testing, ED treatment, and PrEP. Targets a partially overlapping male consumer segment and offers integrated testing-to-treatment pathways that compete with Priority's positive-result consultation workflow.

TypeEmerging player
Description

Telehealth platform offering at-home STI testing kits alongside prescription contraception, HPV screening, and PrEP. Competes for the same privacy-conscious consumer and overlaps in the testing-to-treatment workflow that Priority STD Testing offers via PWNHealth.

TypeDirect peer
Description

Direct-to-consumer STD testing service using the same Quest Diagnostics lab network and offering nearly identical panels (Twin Panel, 10-Panel, individual tests). Operates an almost identical online-order-plus-walk-in-lab model with confidential results, making it the closest head-to-head competitor.

TypeBroad incumbent
Description

One of the two largest clinical laboratory networks in the U.S. and Priority STD Testing's exclusive lab processing partner. Operates the 4,000+ collection sites used by Priority and increasingly competes via its own D2C channels (QuestDirect, Everlywell).

TypeDirect peer
Description

D2C at-home testing company offering STI panels among a broad diagnostics menu. Owned by Quest Diagnostics (Priority STD Testing's lab partner), creating both a competitive threat and a structural risk that Quest could prioritize Everlywell's funnel.

TypeOthers
Description

Other dominant U.S. clinical laboratory network with national collection footprint and a growing direct-to-consumer testing offering (Labcorp OnDemand). Comparable as both a potential lab partner alternative and as an incumbent competing for the same testing demand.

TypeDirect peer
Description

Direct-to-consumer at-home health testing platform offering STI panels alongside broader wellness, hormone, and chronic-condition tests. Backed by significant venture funding, it competes for the same consumer willingness to pay out-of-pocket for private testing.

9STDtesting.com
TypeDirect peer
Description

DTC STD testing provider offering individual and panel tests with online ordering and walk-in lab visits. Closely matches Priority STD Testing's value proposition of convenience, confidentiality, and fast turnaround via national lab partnerships.

TypeOthers
Description

Physician network and clinical services provider supplying Priority STD Testing's telehealth consultation and prescription infrastructure. While a strategic partner rather than a customer-facing competitor, PWNHealth is increasingly enabling direct D2C testing services for other brands, posing both ecosystem dependence and competitive risk.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Priority STD Testing

Direct-to-Consumer STD Testing Servicesprioritystdtesting.com

Priority STD Testing is a St. Louis-based direct-to-consumer STD testing service that sells FDA-approved lab tests online and by phone, processing samples through Quest Diagnostics' 4,000+ collection facilities and delivering results via a secure patient portal within 24-48 hours.

What Priority STD Testing does

Priority STD Testing is a privately held direct-to-consumer STD testing service founded in 2001 and headquartered in St. Louis, Missouri, operating with a team of 1-10 employees. The company enables individuals to purchase FDA-approved laboratory tests online or via phone 24/7, then visit one of more than 4,000 affiliated Quest Diagnostics collection facilities nationwide for sample collection, with results delivered through a secure HIPAA-compliant patient portal typically within 24-48 hours. The company's stated cumulative volume is over 100,000 individuals tested since inception.

The product portfolio spans individual tests priced from $69 to $159 and bundled panels, anchored by a $129 Twin STD Panel (Chlamydia and Gonorrhea) and a $249 10-Panel Test covering HIV (1 Ab, 1 Ag, 2 Ab), Hepatitis B and C, Syphilis, and Herpes 1/2. Specialty offerings include an HIV RNA Early Detection test capable of identifying the virus within 10 days of exposure, Herpes Early Detection with automatic confirmatory Inhibition testing for HSV-2 positives, and a Mycoplasma Genitalium test. Treatment services are provided through PWNHealth-affiliated physicians who conduct phone or video consultations and can prescribe medication for positive Chlamydia, Gonorrhea, or Trichomoniasis results, with a $65 consultation fee.

The business operates on a unit-pricing, pay-as-you-go model with no subscription component. Revenue is generated entirely from upfront test purchases plus optional physician consultation fees; there are no disclosed enterprise contracts, insurance billing arrangements, or recurring revenue streams. Marketing is primarily organic: SEO-optimized educational blog content, organic search, phone-based care counselors, Trustpilot review collection, and earned media coverage in Healthline, Vice, Huffington Post, and Men's Health. All laboratory processing is conducted in CLIA-certified labs via the Quest Diagnostics partnership, and the company is verified as a CDC NPIN provider.

Priority STD Testing firmographics

Firmographics
Name
Priority STD Testing
Legal name
Priority STD Testing
Website
https://prioritystdtesting.com
Company type
Private
Founded year
2001
Operating status
Operating
Headcount range
1–10 employees
Short description
Priority STD Testing is a St. Louis-based direct-to-consumer STD testing service that sells FDA-approved lab tests online and by phone, processing samples through Quest Diagnostics' 4,000+ collection facilities and delivering results via a secure patient portal within 24-48 hours.
Ownership category
akta.pro rank

Priority STD Testing industry classification

Industry
Product category
Direct-to-Consumer STD Testing Services
NAICS
Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)
SIC
Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLALAIAL
Infectious Disease & STI Testing-to-Treatment with eRx + Pharmacy Fulfillment
Healthcare & Life Sciences/Telehealth Platforms/Pharmacy-Integrated Telehealth & ePrescribing Platforms
SECONDARYHLAHAOAA
Infectious Disease POCT (Respiratory, STI, HIV, Sepsis)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Point-of-Care Testing (POCT) & Rapid Diagnostics
SECONDARYHLACAPAK
Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices)
Healthcare & Life Sciences/Digital Health & Health IT/Healthcare IoT & Remote Patient Monitoring
SECONDARYHLAGAEAK
Point-of-Care & Decentralized Trial Testing Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)

Keywords

  • STD testing services
  • Direct-to-consumer testing
  • Sexual health screening
  • Lab testing panels
  • Telehealth consultations

Where Priority STD Testing is headquartered

Location

Headquarters

HQ city
St Louis
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Priority STD Testing business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Operations, Marketing or Sales, Personnel, Technology or R&D, Infrastructure

Revenue model

  1. Direct Test Sales: One-time purchase of STD testing panels and individual tests. Customers order online or by phone, pay upfront, then visit Quest Diagnostics collection facilities for sample collection. Additional $65 physician consultation fee for treatment consultations.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goTwin STD Panel - Chlamydia and Gonorrhea
Unit PricingPay-as-you-go10-Panel STD Test - Comprehensive
Unit PricingPay-as-you-goIndividual STD Tests
Unit PricingPay-as-you-goNew York State Individual Tests
Unit PricingPay-as-you-goPhysician Treatment Consultation

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Priority STD Testing product offering

Product offering

Core offering

Priority STD Testing is a direct-to-consumer STD testing service that lets individuals privately order lab tests online or by phone, visit any of 4,000+ Quest Diagnostics collection facilities nationwide without an appointment for sample collection, and receive confidential results through a secure online portal in 24-48 hours. The company also offers integrated physician consultations and treatment via PWNHealth for positive chlamydia, gonorrhea, or trichomoniasis results, with prescriptions called into local pharmacies.

Product overview

Priority STD Testing operates as a direct-to-consumer STD testing service offering a portfolio of individual tests and bundled panels. The core product lineup includes the Twin STD Panel (Chlamydia and Gonorrhea) and the 10-Panel STD Test as the most comprehensive option covering Hepatitis B, Hepatitis C, Syphilis, Herpes 1/2, and HIV 1/2. Individual standalone tests are available for each condition: Chlamydia ($99), Gonorrhea ($99), Hepatitis B ($69), Hepatitis C ($69), Herpes I/II ($109), HIV 1/2 ($89), Syphilis ($79), Trichomoniasis ($139), and Mycoplasma Genitalium ($159). Advanced early detection tests are offered for HIV RNA (detecting virus as early as 10 days post-exposure) and Herpes. The company also provides complementary physician consultation and treatment services through its PWNHealth partnership, enabling phone/video consults and prescriptions for positive results of curable STDs (Chlamydia, Gonorrhea, Trichomoniasis). Testing is conducted at over 4,000 private collection facilities nationwide with results typically available within 24-72 hours.

Differentiator

Problem solved

Functional benefit

Products and services

  • Twin STD Panel (Chlamydia and Gonorrhea) Dual-test panel that screens for Chlamydia and Gonorrhea infections, priced at $129, for consumers wanting focused bacterial STD screening.
  • 10-Panel STD Test Comprehensive 10-panel test covering Hepatitis B, Hepatitis C, Syphilis, Herpes 1, Herpes 2, HIV 1 Ab, HIV 1 Ag, HIV 2 Ab (plus Chlamydia and Gonorrhea per typical 10-panel composition), priced at $249 as the most popular option.
  • Individual Chlamydia Test Standalone urine/blood test for Chlamydia infection, priced at $99, for patients seeking single-disease screening.
  • Individual Gonorrhea Test Standalone test for Gonorrhea infection, priced at $99, allowing targeted screening for this bacterial STD.
  • Individual Hepatitis B Test Standalone blood test for Hepatitis B virus, priced at $69, screening for liver infection transmittable through sexual contact and blood.
  • Individual Hepatitis C Test Standalone test for Hepatitis C virus, priced at $69, detecting blood-borne liver infection that can be transmitted sexually.
  • Herpes I/II Test Blood test detecting both Herpes Simplex Virus Type 1 (oral herpes) and Type 2 (genital herpes) antibodies, priced at $109.
  • HIV 1/2 Test Standard 4th generation HIV test detecting both HIV-1 and HIV-2 antibodies, priced at $89.
  • Individual Syphilis Test Blood test for Syphilis infection, priced at $79, screening for antibodies to Treponema pallidum bacterium.
  • Individual Trichomoniasis Test Urine test for Trichomoniasis infection, priced at $139, screening for the Trichomonas vaginalis parasite.
  • Mycoplasma Genitalium Test Test for Mycoplasma genitalium infection, priced at $159, offered as part of the company's expanded STD testing menu.
  • HIV RNA Early Detection Test Advanced HIV test detecting viral RNA rather than antibodies, enabling detection as early as 10 days after exposure; results typically process in about 5 business days due to specialty lab requirements.
  • Herpes Early Detection Test Early detection testing for Herpes simplex virus, with automatic confirmatory inhibition testing for HSV-2 positive results at no additional charge.
  • Physician Consultation Service Phone or video consultation with a PWNHealth physician for patients testing positive for Chlamydia, Gonorrhea, or Trichomoniasis, at a $65 consultation fee, enabling prescription medication without an office visit.
  • Treatment Services Prescription treatment for patients testing positive for Chlamydia, Gonorrhea, or Trichomoniasis, with medication called into the patient's pharmacy of choice and typically available same day, delivered via PWNHealth physicians.

Quantifiable outcome

  • Results available in 24-48 hours
  • +2 more outcomes

Companies that use Priority STD Testing

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Priority STD Testing technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

Feature3 records

Priority STD Testing partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • Quest DiagnosticscoreStrategic or Co-development PartnerQuest Diagnostics is the primary laboratory partner responsible for collecting and processing all samples. They operate the 4,000+ collection facilities where customers provide urine and blood samples. Quest Diagnostics is in compliance with federal, state, and local health reporting requirements.
  • PWNHealthcoreStrategic or Co-development PartnerPWNHealth provides administrative services including physician review of test orders, results delivery through secure patient portal, and phone/video consultations for treatment of positive results. PWN physicians can prescribe medication for chlamydia, gonorrhea, and trichomoniasis. Located at 123 W 18th St, New York, NY 10011.
  • TrustpilotminorGTM or Marketing PartnerTrustpilot is used to collect and display customer reviews of the testing experience. Automated review requests are sent via email after testing is complete. No medically related information is disclosed in the review system.

Scale indicators4 records

Recent moves6 records

Expansion highlights3 records

Priority STD Testing competitors and assessment

Company assessment

Direct peers

  • myLAB Box: At-home STI testing company offering mail-in sample collection kits covering chlamydia, gonorrhea, HIV, HPV, and other infections. Competes for the same privacy-conscious, insurance-avoiding consumer segment but differentiates through home collection rather than walk-in labs.
  • STDcheck.com: Direct-to-consumer STD testing service using the same Quest Diagnostics lab network and offering nearly identical panels (Twin Panel, 10-Panel, individual tests). Operates an almost identical online-order-plus-walk-in-lab model with confidential results, making it the closest head-to-head competitor.
  • Everlywell: D2C at-home testing company offering STI panels among a broad diagnostics menu. Owned by Quest Diagnostics (Priority STD Testing's lab partner), creating both a competitive threat and a structural risk that Quest could prioritize Everlywell's funnel.
  • LetsGetChecked: Direct-to-consumer at-home health testing platform offering STI panels alongside broader wellness, hormone, and chronic-condition tests. Backed by significant venture funding, it competes for the same consumer willingness to pay out-of-pocket for private testing.
  • STDtesting.com: DTC STD testing provider offering individual and panel tests with online ordering and walk-in lab visits. Closely matches Priority STD Testing's value proposition of convenience, confidentiality, and fast turnaround via national lab partnerships.

Emerging players

  • Roman (Ro): Telehealth company offering men's sexual health services including STI testing, ED treatment, and PrEP. Targets a partially overlapping male consumer segment and offers integrated testing-to-treatment pathways that compete with Priority's positive-result consultation workflow.
  • Nurx: Telehealth platform offering at-home STI testing kits alongside prescription contraception, HPV screening, and PrEP. Competes for the same privacy-conscious consumer and overlaps in the testing-to-treatment workflow that Priority STD Testing offers via PWNHealth.

Broad incumbents

  • Quest Diagnostics: One of the two largest clinical laboratory networks in the U.S. and Priority STD Testing's exclusive lab processing partner. Operates the 4,000+ collection sites used by Priority and increasingly competes via its own D2C channels (QuestDirect, Everlywell).

Others

  • Labcorp: Other dominant U.S. clinical laboratory network with national collection footprint and a growing direct-to-consumer testing offering (Labcorp OnDemand). Comparable as both a potential lab partner alternative and as an incumbent competing for the same testing demand.
  • PWNHealth: Physician network and clinical services provider supplying Priority STD Testing's telehealth consultation and prescription infrastructure. While a strategic partner rather than a customer-facing competitor, PWNHealth is increasingly enabling direct D2C testing services for other brands, posing both ecosystem dependence and competitive risk.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Priority STD Testing social profiles

Digital presence

Priority STD Testing compliance and trust

Trust signal

Compliance5 records

Priority STD Testing financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Priority STD Testing leadership team

Management profile

Number of profiles

Profiles1 record

Priority STD Testing funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Priority STD Testing M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Priority STD Testing

What does Priority STD Testing do?

Priority STD Testing is a direct-to-consumer STD testing service that lets individuals privately order lab tests online or by phone, visit any of 4,000+ Quest Diagnostics collection facilities nationwide without an appointment for sample collection, and receive confidential results through a secure online portal in 24-48 hours. The company also offers integrated physician consultations and treatment via PWNHealth for positive chlamydia, gonorrhea, or trichomoniasis results, with prescriptions called into local pharmacies.

Is Priority STD Testing a public or private company?

Priority STD Testing is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Priority STD Testing founded?

Priority STD Testing was founded in 2001. It employs 1 to 10 people.

Where is Priority STD Testing based?

Priority STD Testing is headquartered in St Louis, United States, in the North America region.

How does Priority STD Testing make money?

One revenue line is on record: direct Test Sales.

Who are Priority STD Testing's main competitors?

Direct peers on record are myLAB Box, STDcheck.com, Everlywell, LetsGetChecked and STDtesting.com. Emerging players are Roman (Ro) and Nurx. Quest Diagnostics is listed as a broad incumbent. Others are Labcorp and PWNHealth.

Does Priority STD Testing have an API?

No public API is recorded for Priority STD Testing.

What industry is Priority STD Testing in?

Priority STD Testing's product category is Direct-to-Consumer STD Testing Services. Its primary akta.pro industry code is HLALAIAL, Infectious Disease & STI Testing-to-Treatment with eRx + Pharmacy Fulfillment, with a secondary code of HLAHAOAA, Infectious Disease POCT (Respiratory, STI, HIV, Sepsis). Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals